These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

995 related articles for article (PubMed ID: 22993202)

  • 1. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
    Duboc H; Rajca S; Rainteau D; Benarous D; Maubert MA; Quervain E; Thomas G; Barbu V; Humbert L; Despras G; Bridonneau C; Dumetz F; Grill JP; Masliah J; Beaugerie L; Cosnes J; Chazouillères O; Poupon R; Wolf C; Mallet JM; Langella P; Trugnan G; Sokol H; Seksik P
    Gut; 2013 Apr; 62(4):531-9. PubMed ID: 22993202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gut microbiota and IBD].
    Seksik P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S44-51. PubMed ID: 20889004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Li N; Zhan S; Tian Z; Liu C; Xie Z; Zhang S; Chen M; Zeng Z; Zhuang X
    Inflamm Bowel Dis; 2021 Aug; 27(9):1525-1540. PubMed ID: 33399195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
    Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
    J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.
    Higashimura Y; Naito Y; Takagi T; Uchiyama K; Mizushima K; Ushiroda C; Ohnogi H; Kudo Y; Yasui M; Inui S; Hisada T; Honda A; Matsuzaki Y; Yoshikawa T
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G367-75. PubMed ID: 26767984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal steroid profiles and microbiota composition in colitic mice.
    Wohlgemuth S; Keller S; Kertscher R; Stadion M; Haller D; Kisling S; Jahreis G; Blaut M; Loh G
    Gut Microbes; 2011; 2(3):159-66. PubMed ID: 21869607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does canine inflammatory bowel disease influence gut microbial profile and host metabolism?
    Xu J; Verbrugghe A; Lourenço M; Janssens GP; Liu DJ; Van de Wiele T; Eeckhaut V; Van Immerseel F; Van de Maele I; Niu Y; Bosch G; Junius G; Wuyts B; Hesta M
    BMC Vet Res; 2016 Jun; 12(1):114. PubMed ID: 27306031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial flora in inflammatory bowel disease.
    Marteau P
    Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Sitkin S; Pokrotnieks J
    Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
    Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
    Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiota and inflammatory bowel disease.
    Matsuoka K; Kanai T
    Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
    Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
    Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.
    Henson MA; Phalak P
    BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic analysis of bile salt biotransformation in the human gut microbiome.
    Das P; Marcišauskas S; Ji B; Nielsen J
    BMC Genomics; 2019 Jun; 20(1):517. PubMed ID: 31234773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the editor regarding the report of Duboc et al: Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease.
    Jones ML; Martoni CJ; Prakash S
    Gut; 2013 Apr; 62(4):654-5. PubMed ID: 23148122
    [No Abstract]   [Full Text] [Related]  

  • 20. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.
    Jones ML; Martoni CJ; Ganopolsky JG; Labbé A; Prakash S
    Expert Opin Biol Ther; 2014 Apr; 14(4):467-82. PubMed ID: 24479734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.